ReShape Lifesciences Inc. (NASDAQ:RSLS) Q1 2023 Earnings Call Transcript
Michael Miller: Good afternoon, and thank you for joining the ReShape Lifesciences first quarter 2023 earnings call.
Reshape Lifesciences Inc. (RSLS)
Market is closed
Hedge Fund Popularity
Hedge Fund Holdings
Filing Period:
Last updated on based on SEC 13F filings Last update:
| No. | Hedge Fund | Shares | Value (x$1000) | Activity | % Port |
|---|---|---|---|---|---|
| 1. | Renaissance Technologies Jim Simons | 0 | $0 | 0% | |
| 2. | Armistice Capital Steven Boyd | 0 | $0 | 0% | |
| 3. | Citadel Investment Group Ken Griffin | 0 | $0 | 0% |
Insider Trading: Purchases See All
| Insider | Price | Amount | Relationship | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $0.95 | 1,228 | Officer | 365,627 | 2022-05-31 | Filing | |
| $0.94 | 6,539 | Officer | 364,399 | 2022-05-31 | Filing | |
| $0.93 | 60 | Officer | 357,860 | 2022-05-31 | Filing | |
| $0.92 | 7,995 | Officer | 357,800 | 2022-05-31 | Filing | |
| $0.90 | 1,000 | Officer | 349,805 | 2022-05-31 | Filing |
Insider Trading: Sales See All
| Insider | Price | Amount | Relationship | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $4.25 | 103 | Officer | 6,091 | 2023-02-28 | Filing | |
| $13.29 | 157 | Officer | 6,194 | 2023-02-02 | Filing | |
| $7.49 | 110 | Officer | 6,351 | 2023-01-24 | Filing | |
| $7.49 | 48 | Officer | 6,461 | 2023-01-24 | Filing | |
| $0.15 | 2,213 | Officer | 325,404 | 2022-12-01 | Filing |
Institutional Investors' Holdings
Filing Period:
| No. | Name | Shares | Value (x$1000) | % Port |
|---|---|---|---|---|
| 1. | 0 | $0 | 0% | |
| 2. | 0 | $0 | 0% | |
| 3. | 0 | $0 | 0% | |
| 4. | 0 | $0 | 0% | |
| 5. | 0 | $0 | 0% |
News See All
Billionaire Hedge Funds
